๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cisplatin and radiotherapy in the management of locally advanced head and neck cancer

โœ Scribed by Arlene A Forastiere

Book ID
107964571
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
800 KB
Volume
27
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Concomitant weekly cisplatin and altered
Concomitant weekly cisplatin and altered fractionation radiotherapy in locally advanced head and neck cancer
โœ Heather E. Newlin; Robert J. Amdur; Charles E. Riggs; Christopher G. Morris; Jes ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 144 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND: Both concomitant chemotherapy and altered fractionation radiotherapy (RT) have been shown to improve outcomes for patients with locoregionally advanced head and neck squamous cell carcinomas. However, both strategies also increase acute toxicity, and it is questionable w

Hyperfractionated accelerated radiothera
Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer
โœ Gabriele K. Beckmann; Florian Hoppe; Leo Pfreundner; Michael P. Flentje ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 267 KB ๐Ÿ‘ 2 views

## Background: The purpose of this study was to determine the feasibility and efficacy of hyperfractionated accelerated radiotherapy (hfrcb) combined with simultaneous chemotherapy with weekly cisplatin (cddp) in locally advanced inoperable head and neck cancer. ## Methods: From august 1999 to de

Locally advanced head and neck cancer
Locally advanced head and neck cancer
โœ Merrill S. Kies; Charles L. Bennett; Everett E. Vokes ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› Springer ๐ŸŒ English โš– 202 KB
High-dose cisplatin in advanced head and
High-dose cisplatin in advanced head and neck cancer
โœ Arlene A. Forastiere; Bonnie J. Takasugi; Shan R. Baker; Gregory T. Wolf; Vickie ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› Springer ๐ŸŒ English โš– 452 KB

In 22 patients with advanced squamous cell carcinoma of the head and neck we evaluated the efficacy and toxicity of 200 mg/m2 cisplatin administered in 3% NaCl with vigorous hydration. Six patients had previously untreated stage IV disease and 16 patients had recurrent disease, including eight with